High income (World Bank) vs Norway: Previously treated cases tested for RR-/MDR-TB
High income (World Bank)
92.0%
in 2024
Norway
100.0%
in 2024
High income (World Bank) rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- High income (World Bank)
- Norway
How they compare
Norway currently reports 100.0% against 92.0% in High income (World Bank), a difference of 8.0%.
That makes Norway's figure about 1.1 times High income (World Bank)'s.
The two have swapped places 6 times across 20 shared years of data; in 2005 it was Norway ahead.
High income (World Bank) ranks 1st and Norway ranks 1st of 11 groups.
Across the 3 decades both report, High income (World Bank) averaged higher in 1 and Norway in 2.
Head to head by decade
| Decade | High income (World Bank) | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 11.9% | 60.0% | 48.1% | Norway |
| 2010s | 49.4% | 62.5% | 13.1% | Norway |
| 2020s | 91.2% | 89.4% | 1.8% | High income (World Bank) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, High income (World Bank) or Norway?
- Norway, at 100.0% against 92.0% in High income (World Bank) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between High income (World Bank) and Norway?
- 8.0%, with Norway ahead.
- How many years of comparable data are there for High income (World Bank) and Norway?
- 20 years are reported by both, from 2005 to 2024.
- How do High income (World Bank) and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- High income (World Bank) ranks 1st and Norway ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.